MHM Magazine

References: 1. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments analysis. Lancet 2009;373(9665): 746-758. 2 . Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus other antidepressants for depression. Cochrane Database Syst Rev 2014;(4):CD006117. Doi:10.1002/14651858.CD006117.pub4. 3. Parissis J, Fountoulaki K, Paraskevaidis I, et al. Sertraline for the treatment of depression in coronary artery disease and heart failure. Expert Opin Pharmacother 2007;8(10):1529-1537. 4 . Muijsers RB, Plosker GL, Noble S. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 2002;19(5):377-392. 5. Data on file. Bioequivalence study of sertraline. S5 SERLIFE ® 50 mg (Film-coated tablets). Reg. No.: 36/1.2/0272. Each film-coated tablet contains sertraline hydrochloride equivalent to sertraline 50 mg. Sugar free. S5 SERLIFE ® 100 mg (Film-coated tablets). Reg. No.: 36/1.2/0273. Each film-coated tablet contains sertraline hydrochloride equivalent to sertraline 100 mg. Sugar free. Pharmacological classification: A 1.2 Psychoanaleptics (Antidepressants). Applicant: Ranbaxy (S.A.) (Pty) Ltd., a Sun Pharma company. Ground Floor, Tugela House, Riverside Office Park, 1303 Heuwel Avenue, Centurion, 0046. Tel: +27 12 643 2000. Fax: +27 12 643 2001 . www.sunpharma.com . For full prescribing information please refer to the package inserts approved by the South African Health Products Regulatory Authority. SSRI = selective serotonin-reuptake inhibitor